This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, November 15, 2013
Watch - Fibroscan offers timely alternative in liver scans
The new machine called a fibroscan is a timely and welcome alternative to a needle biopsy as diseases of the liver increase.
No comments:
Post a Comment